What is pink eye

Overview of Pink Eye

Pink eye, medically known as conjunctivitis, is inflammation of the conjunctiva—the thin, clear membrane that covers the whites of the eyes and lines the inner eyelids. This inflammation causes the characteristic redness, itching, tearing, and discharge that defines the condition. Pink eye represents one of the most common eye conditions globally, with approximately 6 million cases occurring annually in the United States alone, resulting in over 1 million emergency department visits and 2 million outpatient visits annually. The condition affects individuals across all age groups but is particularly common in children aged 4-6 years, who experience rates 2-3 times higher than adults. Pink eye can be acute (sudden onset with rapid progression) or chronic (lasting more than 4 weeks), with acute cases representing 90% of presentations. The severity ranges from mild irritation causing minimal symptoms to severe inflammation impairing vision temporarily. Unlike other eye conditions, pink eye is usually not vision-threatening when properly managed, though certain bacterial strains can cause complications in rare cases.

Types of Conjunctivitis and Causation

Pink eye exists in three primary forms distinguished by their underlying causes and treatment requirements. Viral conjunctivitis, accounting for 80% of infectious cases, results from viral infections including adenovirus (accounting for 65-70% of viral cases), enterovirus, and herpes simplex virus. Viral pink eye spreads through direct contact with infected eye secretions, respiratory droplets, and contaminated surfaces, making it highly contagious with transmission rates of 30-50% among household contacts. Symptoms of viral pink eye typically appear 24-48 hours after exposure and include watery discharge, mild to moderate pain, and sensitivity to light. Bacterial conjunctivitis, representing 15-20% of infectious cases, stems from bacteria including Staphylococcus aureus (25-30% of bacterial cases), Streptococcus pneumoniae (20-25% of cases), and Haemophilus influenzae (15-20% of cases). Bacterial pink eye produces thick, purulent discharge often causing eyelids to stick together, particularly upon waking. Allergic conjunctivitis, affecting 20% of the population annually, results from allergic reactions to pollen, dust mites, pet dander, or contact lens solution proteins. Allergic pink eye typically produces itching rather than discharge and shows seasonal variations, peaking in spring and fall when outdoor pollen counts reach 2-5 times baseline levels. Other less common causes include chemical irritation (affecting 1-2% of cases), fungal infections (less than 1% of cases primarily in immunocompromised individuals), and toxic reactions to medications or contact lens solutions.

Symptoms and Diagnostic Characteristics

Pink eye presents with distinct symptoms that vary depending on the underlying cause. Common symptoms across all types include conjunctival redness, eye irritation, itching or burning sensations, tearing or watery discharge, and sensitivity to light ranging from mild to severe. Specific symptom patterns help distinguish between types: viral pink eye typically produces clear to slightly milky watery discharge with prominent tearing; bacterial pink eye produces thick, yellowish-green purulent discharge causing eyelids to mat together; allergic pink eye emphasizes intense itching with minimal discharge. Symptom onset typically occurs 24-48 hours after exposure to infectious agents, though allergic reactions can occur within minutes of allergen contact. Vision changes are generally minimal in uncomplicated pink eye, though severe inflammation can temporarily cause slight blurring that resolves as inflammation decreases. Eyelid swelling (chemosis) occurs in 30-40% of cases, particularly in severe viral infections. Preauricular lymph node enlargement, felt as a small bump in front of the ear, occurs in 50-60% of viral cases but less frequently in bacterial cases. Neonatal conjunctivitis, affecting 1-2% of newborns when contracted during birth, presents with more severe symptoms including puffy eyelids, significant discharge, and potential sight-threatening complications if untreated.

Common Misconceptions About Pink Eye

A primary misconception is that all pink eye requires antibiotic treatment. In reality, viral pink eye—the most common type at 80% of cases—does not respond to antibiotics and typically resolves independently within 7-14 days. Prescribing antibiotics for viral pink eye contributes to antibiotic resistance and exposes patients to unnecessary medication side effects. Another widespread belief is that pink eye always requires immediate treatment with drops. Viral and allergic forms often respond well to supportive care including cool compresses, lubricating drops, and avoidance of irritants, with treatment primarily focused on symptom management rather than curing the infection. A third misconception suggests that pink eye causes permanent vision loss. While severe, untreated bacterial cases can rarely lead to complications like corneal scarring (occurring in less than 0.5% of cases), the vast majority of pink eye cases—99.5% or more—resolve completely without vision consequences. Additionally, many people believe pink eye contagiousness ends when redness disappears. Viral pink eye remains contagious for 7-14 days, even after redness resolves, while bacterial pink eye becomes non-contagious 24 hours after antibiotic initiation. The misconception that glasses provide protection from pink eye is partially incorrect; while they reduce contact with fingers and external particles, proper hand hygiene and not touching the eyes provide greater protection than eyewear alone.

Treatment and Management Approaches

Pink eye treatment approaches vary significantly based on the underlying cause and disease severity. Viral pink eye management focuses on supportive care, as no antiviral treatment exists for most viral causes except herpes simplex conjunctivitis. Supportive measures include applying cool or warm compresses 3-4 times daily, using preservative-free artificial tears 4-6 times daily, and avoiding contact lens wear for 1-2 weeks. Symptoms typically improve within 3-5 days though viral shedding continues for 7-14 days. Bacterial pink eye requires topical antibiotic drops including fluoroquinolones (ofloxacin, ciprofloxacin), aminoglycosides (gentamicin), or macrolides (azithromycin), applied 4-6 times daily for 5-7 days. Bacterial pink eye becomes non-contagious within 24 hours of starting appropriate antibiotics, allowing children to return to school or childcare after 24-48 hours of treatment. Allergic conjunctivitis treatment includes avoiding allergen exposure when possible, cool compresses, and topical antihistamines or mast cell stabilizers applied 2-4 times daily. Topical antihistamines like ketotifen provide rapid relief of itching within 15-30 minutes, while mast cell stabilizers like lodoxamide require 1-2 weeks for maximum benefit but provide longer-lasting symptom control. Severe cases may require short-term topical corticosteroids under ophthalmologic supervision to avoid potential steroid-related complications. All forms benefit from meticulous hand hygiene, avoiding eye touching, not sharing towels or cosmetics, and replacing contact lenses and cases if worn during infection. Vision typically remains unaffected throughout treatment in the vast majority of cases.